Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 53:612-619, doi:10.1016/j.jacc.2008.10.044
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haïssaguerre, M.
Right arrow Articles by Clémenty, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Haïssaguerre, M.
Right arrow Articles by Clémenty, J.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: HEART RHYTHM DISORDER

Characteristics of Recurrent Ventricular Fibrillation Associated With Inferolateral Early Repolarization

Role of Drug Therapy

Michel Haïssaguerre, MD*,*, Frederic Sacher, MD*, Akihiko Nogami, MD#, Nohiriro Komiya, MD**, Anne Bernard, MD{dagger}, Vincent Probst, MD, PhD{ddagger}, Sinikka Yli-Mayry, MD||||, Pascal Defaye, MD§, Yoshifusa Aizawa, MD{dagger}{dagger}, Robert Frank, MD||, Roberto Mantovan, MD{ddagger}{ddagger}, Riccardo Cappato, MD§§, Christian Wolpert, MD¶¶, Antoine Leenhardt, MD||, Luc de Roy, MD{ddagger}{ddagger}{ddagger}, Hein Heidbuchel, MD{dagger}{dagger}{dagger}, Isabel Deisenhofer, MD##, Thomas Arentz, MD***, Jean-Luc Pasquié, MD, PhD, Rukshen Weerasooriya, MD*, Meleze Hocini, MD*, Pierre Jais, MD*, Nicolas Derval, MD*, Pierre Bordachar, MD* and Jacques Clémenty, MD*

* Université Bordeaux, CHU Bordeaux, Bordeaux, France
{dagger} Centre Hospitalier Universitaire de Tours, Tours, France
{ddagger} Centre Hospitalier Universitaire de Nantes, Nantes, France
§ Centre Hospitalier Universitaire de Grenoble, Grenoble, France
|| Centre Hospitalier Universitaire de Paris, Paris, France
Centre Hospitalier Universitaire de Montpellier, Montpellier, France
# Yokohama Rosai Hospital, Yokohama, Japan
** Nagasaki University, Nagasaki, Japan
{dagger}{dagger} Niigata University School, Niigata, Japan
{ddagger}{ddagger} Treviso Hospital, Treviso, Italy
§§ Policlinico San Donato, Milano, Italy
|||| Tampere University Hospital, Tampere, Finland
¶¶ University Hospital Mannheim, Mannheim, Germany
## University Hospital Herzzentrum Munich, Munich, Germany
*** University Hospital Bad Krozingen, Bad Krozingen, Germany
{dagger}{dagger}{dagger} University Hospital Leuven, Leuven, Belgium
{ddagger}{ddagger}{ddagger} Clinique MontGodinne, MontGodinne, Belgium

Manuscript received July 22, 2008; revised manuscript received October 8, 2008, accepted October 26, 2008.

* Reprint requests and correspondence: Dr. Michel Haïssaguerre, Hôpital Cardiologique du Haut-Lévêque, 33604 Bordeaux-Pessac, France (Email: michel.haissaguerre{at}chu-bordeaux.fr).

Objectives: Our purpose was to evaluate the efficacy of antiarrhythmic drugs (AADs) in recurrent ventricular fibrillation (VF) associated with inferolateral early repolarization pattern on the electrocardiogram.

Background: Although an implantable cardioverter-defibrillator is the treatment of choice, additional AADs may be necessary to prevent frequent episodes of VF and reduce implantable cardioverter-defibrillator shock burden or as a lifesaving therapy in electrical storms.

Methods: From a multicenter cohort of 122 patients (90 male subjects, age 37 ± 12 years) with idiopathic VF and early repolarization abnormality in the inferolateral leads, we selected all patients with more than 3 episodes of VF (multiple) including those with electrical storms (≥3 VF in 24 h). The choice of AAD was decided by individual physicians. Follow-up data were obtained for all patients using monitoring with implantable defibrillator. Successful oral AAD was defined as elimination of all recurrences of VF with a minimal follow-up period of 12 months.

Results: Multiple episodes of VF were observed in 33 (27%) patients. Electrical storms (34 ± 47 episodes) occurred in 16 and were unresponsive to beta-blockers (11 of 11), lidocaine/mexiletine (9 of 9), and verapamil (3 of 3), while amiodarone was partially effective (3 of 10). In contrast, isoproterenol infusion immediately suppressed electrical storms in 7 of 7 patients. Over a follow-up of 69 ± 58 months, oral AADs were poorly effective in preventing recurrent VF: beta-blockers (2 of 16), verapamil (0 of 4), mexiletine (0 of 4), amiodarone (1 of 7), and class 1C AADs (2 of 9). Quinidine was successful in 9 of 9 patients, decreasing recurrent VF from 33 ± 35 episodes to nil for 25 ± 18 months. In addition, quinidine restored a normal electrocardiogram.

Conclusions: Multiple recurrences of VF occurred in 27% of patients with early repolarization abnormality and may be life threatening. Isoproterenol in acute cases and quinidine in chronic cases are effective AADs.

Key Words: early repolarization • sudden cardiac death • ventricular fibrillation • electrical storm • antiarrhythmic drugs

Abbreviations and Acronyms
  AAD = antiarrhythmic drug
  ICD = implantable cardioverter-defibrillator
  IQR = interquartile range
  VF = ventricular fibrillation


Related Articles

Idiopathic Ventricular Fibrillation "Le Syndrome d'Haïssaguerre" and the Fear of J Waves
Sami Viskin
J. Am. Coll. Cardiol. 2009 53: 620-622. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A32. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ Arrhythm ElectrophysiolHome page
S. Kamakura, T. Ohe, K. Nakazawa, Y. Aizawa, A. Shimizu, M. Horie, S. Ogawa, K. Okumura, K. Tsuchihashi, K. Sugi, et al.
Long-Term Prognosis of Probands With Brugada-Pattern ST-Elevation in Leads V1-V3
Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 495 - 503.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. M. Marcus, E. Keung, and M. M. Scheinman
The year in review of clinical cardiac electrophysiology.
J. Am. Coll. Cardiol., August 25, 2009; 54(9): 777 - 787.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Viskin
Idiopathic Ventricular Fibrillation "Le Syndrome d'Haissaguerre" and the Fear of J Waves.
J. Am. Coll. Cardiol., February 17, 2009; 53(7): 620 - 622.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement